Abstract: The invention relates to an electrode body (20) of an electrode assembly for electrically stimulating tissue of a living being, more particularly for neurostimulation. The electrode body (20) is designed to be arranged at a point between the skull and the scalp of a living being. The electrode body (20) has a stimulation surface, which is designed to be brought into contact with the tissue of the living being in order to produce an electrical stimulation of the tissue by alternating-current pulses and/or direct-current pulses.

Abstract: The invention relates to an electrode body (20) of an electrode assembly for electrically stimulating tissue of a living being, more particularly for neurostimulation. The electrode body (20) is designed to be arranged at a point between the skull and the scalp of a living being. The electrode body (20) has a stimulation surface, which is designed to be brought into contact with the tissue of the living being in order to produce an electrical stimulation of the tissue by alternating-current pulses and/or direct-current pulses.

Abstract: The invention relates to an electrode body (20) of an electrode assembly for electrically stimulating tissue of a living being, more particularly for neurostimulation. The electrode body (20) is designed to be arranged at a point between the skull and the scalp of a living being. The electrode body (20) has a stimulation surface, which is designed to be brought into contact with the tissue of the living being in order to produce an electrical stimulation of the tissue by alternating-current pulses and/or direct-current pulses.

Abstract: The invention relates to a drug-coated balloon catheter and to a method for producing the same. The balloon of the catheter includes (i) a main membrane, and (ii) an asymmetrical polymer membrane which is applied to an outside of the main membrane and into which at least one pharmaceutical active ingredient is introduced.

Abstract: The invention relates to a drug-coated balloon catheter and to a method for producing the same. The balloon of the catheter includes (i) a main membrane, and (ii) an asymmetrical polymer membrane which is applied to an outside of the main membrane and into which at least one pharmaceutical active ingredient is introduced.

Abstract: The invention relates to a catheter, in particular an endovascular catheter, having an applicator device for liquid active substances for applying same to an active substance storage zone mounted on the catheter.

Abstract: The invention relates to an implantable drug reservoir (10) having a cavity (28) enclosed by a sheathing (12) and arranged between a proximal end (14) and a distal end (16) for storing one or more drugs (50), having an outlet opening (24) for the drug(s) (50). The drug(s) (50) can be delivered to a delivery region (70) through a puncture device (20) at one end (16). The invention also relates to a device (100) having a drug reservoir (10).

Abstract: The invention relates to an implantable device for local release of at least one drug at a predefined location in a natural cavity having a wall in the body of a mammal, characterized by at least one drug reservoir, which can be affixed in the cavity, the drug reservoir and/or a drug outlet being arranged at a distance from the wall, such that the at least one drug is released at a distance from the wall.

Abstract: One embodiment of the invention relates to an implant with a coating containing at least one active pharmaceutical substance. The inventive implant is characterized in that the coating is covered by a protective layer comprising or containing one or more materials from the group including shellac, vinylpyrrolidone-vinyl acetate copolymer, vinyl acetate-crotonic acid copolymer, vinyl acetate-vinyl propionate-crotonic acid terpolymer, methylvinyl ether-maleic anhydride copolymer, vinylpyrrolidone-dimethylaminoethyl acrylate copolymer, polyvinylpyrrolidone, polyvinyl acetate, polycrotonic acid, polyvinyl propionate, polymethylvinyl ether, polymaleic anhydride and polydimethylaminoethyl acrylate.

Abstract: The invention relates to a drug-coated balloon catheter and to a method for producing the same. The balloon of the catheter includes (i) a main membrane, and (ii) an asymmetrical polymer membrane which is applied to an outside of the main membrane and into which at least one pharmaceutical active ingredient is introduced.

Abstract: The invention relates to a catheter, in particular an endovascular catheter, having an applicator device for liquid active substances for applying same to an active substance storage zone mounted on the catheter.

Abstract: An implantable sensor for measuring fluidic parameters with a surface acoustic wave transponder for detecting vasomotor quantities and one retaining stent attached to each of two opposite ends of the surface acoustic wave transponder.

Abstract: The invention relates to a drug-loaded implant having a carrier body (10) and at least one drug for delivery into a delivery region. The drug is provided for chemotherapy and/or palliative treatment and can be released topically and/or regionally in a controlled manner at a predefinable rate and/or over a predefinable period of time in the intended active state of the implant.

Abstract: The invention relates to an implantable device for local release of at least one drug at a predefined location in a natural cavity having a wall in the body of a mammal, characterized by at least one drug reservoirs, which can be affixed in the cavity, the drug reservoirs and/or a drug outlet being arranged at a distance from the wall, such that the at least one drug is released at a distance from the wall.

Abstract: The invention relates to an implantable drug reservoir (10) having a cavity (28) enclosed by a sheathing (12) and arranged between a proximal end (14) and a distal end (16) for storing one or more drugs (50), having an outlet opening (24) for the drug(s) (50). The drug(s) (50) can be delivered to a delivery region (70) through a puncture device (20) at one end (16). The invention also relates to a device (100) having a drug reservoir (10).

Abstract: A stent having a main body made of a biodegradable material and an active coating applied to the main body, which comprises a biodegradable carrier matrix and at least one pharmaceutically active substance embedded in the carrier matrix.

Abstract: A drug depot suitable for the parenteral, in particular intravascular, release of at least one drug which may be present as a base or corresponding protonised salt, wherein the base has a pKb value ranging from 2 to 6. The drug depot contains elementary magnesium in a biocorrodible form for this purpose.

Abstract: A system for treating extensive obliterative vascular diseases, in which the severity of the disease is different in different vascular sections, comprises: one or more biocorrodible stents arranged with a distance between them in sections of the diseased vessel that have been dilated by transluminal angioplasty, and a device adapted for release of an active ingredient in the lumen or in the vascular tissue, designed (i) to release the active ingredient in the lumen of the diseased vessel, whereby the active ingredient is released in a vascular section at the greatest distance proximally in the direction of blood flow in the vessel; or (ii) to release the active ingredient in the vascular tissue whereby the active ingredient is released in one or more vascular sections of the vessel to be treated so that the active ingredient can spread throughout the area of the diseased vessel through diffusion.

Abstract: The invention concerns an implantable stent (10) with an at least portion-wise polymeric coating (16). The coating material is admittedly intended to bond to known materials but by virtue of its properties it is intended to enjoy improved compatibility and reduce inflammatory and proliferative processes which can lead to restenosis. That is achieved in that the polymeric coating (16) in the implantable condition after production and sterilization contains poly-L-lactide of a mean molecular weight of more than 200 kDa.